New leukemia drug asciminib tested in everyday patients
NCT ID NCT07549516
First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study looks at how well the drug asciminib works and is tolerated in adults with a type of blood cancer called chronic myeloid leukemia (CML). It includes both newly diagnosed patients and those who have already tried one other treatment. Researchers will track how many patients achieve a key blood test milestone (major molecular response) after 12 months, using real-world data from clinics in Germany.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, CHRONIC MYELOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGMunich, Bavaria, 81241, Germany
-
Novartis Investigative Site
RECRUITINGBremerhaven, Free Hanseatic City of Bremen, 27576, Germany
-
Novartis Investigative Site
RECRUITINGOffenbach, Hesse, 63065, Germany
-
Novartis Investigative Site
RECRUITINGCologne, North Rhine-Westphalia, 50677, Germany
-
Novartis Investigative Site
RECRUITINGZittau, Saxony, 02763, Germany
-
Novartis Investigative Site
RECRUITINGBad Liebenwerda, 04924, Germany
-
Novartis Investigative Site
RECRUITINGBerlin, 12487, Germany
-
Novartis Investigative Site
RECRUITINGBuchholz Nordheide, 21244, Germany
-
Novartis Investigative Site
RECRUITINGCottbus, 03046, Germany
-
Novartis Investigative Site
RECRUITINGDetmold, 32756, Germany
-
Novartis Investigative Site
RECRUITINGHanover, 30625, Germany
-
Novartis Investigative Site
RECRUITINGParchim, 19370, Germany
-
Novartis Investigative Site
RECRUITINGPotsdam, 14467, Germany
-
Novartis Investigative Site
RECRUITINGSchorndorf, 73614, Germany
-
Novartis Investigative Site
RECRUITINGStade, 21680, Germany
Conditions
Explore the condition pages connected to this study.